OMIX

Plasma and Tissue Metabolomics in Renal Cancer Patients with Von Hippel-Lindau Syndrome

OMIX005906

1Summary
Title Plasma and Tissue Metabolomics in Renal Cancer Patients with Von Hippel-Lindau Syndrome
Description This project delves into the metabolic alterations associated with renal cell carcinoma (RCC) in patients suffering from Von Hippel-Lindau (VHL) Syndrome, an autosomal dominant cancer syndrome marked by a high mortality rate due to RCC. Our objective is to harness metabolomics to pinpoint specific and sensitive metabolite markers in this unique patient group, thereby aiding in the broader screening, early diagnosis, intervention, and prognosis of VHL-RCC. Analyzing plasma from 61 VHL-RCC patients and 31 healthy controls, along with 19 paired RCC tumor and adjacent non-malignant tissue samples, we employed Liquid Chromatography-Mass Spectrometry for metabolomics. This approach led to the identification of critical metabolite markers, uncovering metabolic insights for the therapeutic development of this disease.
Organism Homo sapiens
Data Type Metabolome Data by Mass Spectrometry (MS)
Data Accessibility Open-access
BioProject PRJCA023957
Release Date 2024-06-17
Submitter Kan Gong (gongkan_pku@126.com)
Organization Peking University First Hospital
Submission Date 2024-02-29
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX005906-01 Turmor and adjacent non-malignant tissue 1 Metabolome Data by Mass Spectrometry (MS) 305.4 MB rar 0
OMIX005906-04 Plasma 1 Metabolome Data by Mass Spectrometry (MS) 664.93 MB rar 0

View All Released Data of OMIX